They Kept Paying The Same Price For Their Own Stock

30‑Second Take

Why now? A former Wall Street darling has been left for dead. The people running the company are buying shares on the open market with their own cash.

That's not the kind of signal you find on a screener.

CELH closed Friday near $28, sitting close to the bottom of a 52-week range that once stretched to $67. The crowd has walked away. Management hasn't.

Three insiders committed about $1.8 million of their own money across four open-market purchases in five sessions, and every fill landed between $27.44 and $28.00. Beat-up growth name, a fresh insider cluster, and a price band you can measure your risk against. That's the setup.

Trade Setup

Time frame: Swing to medium-term (4 to 12 weeks)

Edge type: Insider cluster buying at a defined price band

Snapshot Table

Chart

1-Month Synopsis: CELH has been under pressure, hugging the low end of its 52-week range in the high $20s and holding a tight $27 to $28 band for the past two weeks. This isn't a stock in an uptrend, and pretending otherwise won't help you.

What matters is that the recent drift lower has stalled, and the fresh insider buying lines up with that stabilization. Want confirmation before jumping in? Watch for a clean move back above $30 on above-average volume. That's your first sign buyers are stepping back in.

Bull Case 

Core thesis: Celsius Holdings makes functional energy drinks, a category that keeps eating share from legacy soda and traditional energy brands.

The core story hasn't broken. It just got repriced.

The market took the growth premium away, but the business itself is intact, and your entry gets you close to what insiders view as a floor.

Catalysts: Three insiders stepped into the open market inside one week, and that is one of the strongest forward signals you can get. CEO John Fieldly bought 18,000 shares at $27.4357 on September 10, roughly $494,000.

Director Damon DeSantis bought 20,000 shares at $27.65 on September 14 and another 16,000 at $27.95 on September 15, about $1.0 million between them. Director Hal Kravitz bought 12,000 shares at $28.00 on September 15, about $336,000.

Four purchases, three buyers, 66,000 shares, roughly $1.8 million, all inside a sixty cent band (Form 4 filings, September 10 to 16).

Executives don't buy their own stock because they're feeling generous. They buy when they see something you're missing, whether that's stabilization in top-line trends, an inflection in international growth, or better shelf placement heading into 2027.

The next scheduled event that could drive a re-rating is the third quarter report, currently calendared for November 4. So your thesis here is less about a near-term print and more about the insider signal and the valuation reset playing out over the coming months.

Valuation upside: You are buying alongside insiders at their own cost basis, not above it. Friday's close of about $28 sits within a couple of cents of the highest price any of the three paid, so your entry and theirs are effectively the same trade.

Add a roughly $7.2 billion market cap and a beta of 0.92, and you get a setup where the stock can move on company-specific news without the broader market dragging it around.

Bear Case 

What could break it: Sell-through decelerated hard, competition from Alani Nu and other functional brands ate into shelf space, and the growth narrative that once justified a nosebleed multiple evaporated.

None of that is fully behind the business yet.

Consumer defensive is getting tricky, too. If the consumer wallet keeps tightening into 2027, discretionary energy drinks are the first line item to get cut, and Celsius plays in the premium end of the category.

Valuation risk: Insider buying can be more optics than conviction. Executives sometimes buy small amounts to signal confidence without actually believing in a near-term turnaround.

What you want is meaningful dollar amounts and repeat buying rather than a single token purchase, which is what this cluster gives you. What it does not give you is a CFO purchase, and that absence is worth noting.

Even with the drawdown, CELH isn't screamingly cheap on forward earnings if growth stays broken. A trailing P/E north of 100 leaves little room for error. This only works if the business inflects.

How to size it: A stock that has been cut roughly in half doesn't rebound in a straight line. You could easily see another test of the low $20s before this turns.

Size the position so a 15% adverse move doesn't force you out. Start with a partial entry now, keep dry powder for a retest, and set your stop below the 52-week low near $24. Don't fall in love with the story.

Quick Checklist 

✅ Thesis still valid after today's close
✅ Volume confirms any move above $30
✅ Insider buying pattern continues (watch Form 4 filings this week)
✅ Price holds the $27 to $28 insider band

Deep‑Dive Links

• Latest earnings report

• Analyst ratings and price targets

• Short interest data

• Company profile and investor relations

That’s all for today’s Everyday Alpha. We’ll have a new pick for you every morning before the market opens, so stay tuned!

Best Regards,
—Noah Zelvis
Everyday Alpha